nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR1A—stomach cancer	0.466	1	CbGaD
Pergolide—HTR2A—myenteric nerve plexus—stomach cancer	0.00544	0.121	CbGeAlD
Pergolide—HTR2A—vagus nerve—stomach cancer	0.00363	0.0806	CbGeAlD
Pergolide—HTR2A—vein—stomach cancer	0.00351	0.0778	CbGeAlD
Pergolide—HTR1B—blood vessel—stomach cancer	0.00231	0.0514	CbGeAlD
Pergolide—HTR1D—blood vessel—stomach cancer	0.00224	0.0497	CbGeAlD
Pergolide—DRD5—hematopoietic system—stomach cancer	0.00199	0.0442	CbGeAlD
Pergolide—Cabergoline—ADRB1—stomach cancer	0.00155	0.25	CrCbGaD
Pergolide—ADRA1D—epithelium—stomach cancer	0.00146	0.0324	CbGeAlD
Pergolide—DRD5—lymphoid tissue—stomach cancer	0.0014	0.0311	CbGeAlD
Pergolide—Cabergoline—HTR1A—stomach cancer	0.00139	0.223	CrCbGaD
Pergolide—Cabergoline—ADRB2—stomach cancer	0.00131	0.21	CrCbGaD
Pergolide—DRD5—endocrine gland—stomach cancer	0.00114	0.0254	CbGeAlD
Pergolide—HTR2A—blood vessel—stomach cancer	0.00111	0.0247	CbGeAlD
Pergolide—Lisuride—ADRB1—stomach cancer	0.00104	0.167	CrCbGaD
Pergolide—HTR1A—hematopoietic system—stomach cancer	0.000995	0.0221	CbGeAlD
Pergolide—HTR2B—smooth muscle tissue—stomach cancer	0.000978	0.0217	CbGeAlD
Pergolide—Lisuride—HTR1A—stomach cancer	0.000932	0.15	CrCbGaD
Pergolide—ADRA1D—endocrine gland—stomach cancer	0.000917	0.0204	CbGeAlD
Pergolide—ADRA1A—hematopoietic system—stomach cancer	0.000917	0.0203	CbGeAlD
Pergolide—KCNH2—hematopoietic system—stomach cancer	0.000885	0.0196	CbGeAlD
Pergolide—ADRA1A—epithelium—stomach cancer	0.000838	0.0186	CbGeAlD
Pergolide—HTR2B—digestive system—stomach cancer	0.000772	0.0171	CbGeAlD
Pergolide—ADRA2C—pancreas—stomach cancer	0.000711	0.0158	CbGeAlD
Pergolide—HTR1B—endocrine gland—stomach cancer	0.000708	0.0157	CbGeAlD
Pergolide—ADRA2A—hematopoietic system—stomach cancer	0.000697	0.0155	CbGeAlD
Pergolide—ADRA1A—lymphoid tissue—stomach cancer	0.000645	0.0143	CbGeAlD
Pergolide—HTR2A—hematopoietic system—stomach cancer	0.000593	0.0132	CbGeAlD
Pergolide—HTR1A—endocrine gland—stomach cancer	0.000572	0.0127	CbGeAlD
Pergolide—KCNH2—bone marrow—stomach cancer	0.000568	0.0126	CbGeAlD
Pergolide—ADRA2A—pancreas—stomach cancer	0.000568	0.0126	CbGeAlD
Pergolide—CYP3A4—hematopoietic system—stomach cancer	0.000549	0.0122	CbGeAlD
Pergolide—HTR2A—epithelium—stomach cancer	0.000542	0.012	CbGeAlD
Pergolide—CYP2D6—hematopoietic system—stomach cancer	0.00054	0.012	CbGeAlD
Pergolide—ADRA1A—endocrine gland—stomach cancer	0.000527	0.0117	CbGeAlD
Pergolide—HTR2A—smooth muscle tissue—stomach cancer	0.000522	0.0116	CbGeAlD
Pergolide—DRD2—endocrine gland—stomach cancer	0.000516	0.0115	CbGeAlD
Pergolide—KCNH2—endocrine gland—stomach cancer	0.000509	0.0113	CbGeAlD
Pergolide—ADRA1A—liver—stomach cancer	0.000475	0.0105	CbGeAlD
Pergolide—ADRA2C—liver—stomach cancer	0.000453	0.01	CbGeAlD
Pergolide—HTR2B—lymph node—stomach cancer	0.000441	0.00978	CbGeAlD
Pergolide—HTR2A—digestive system—stomach cancer	0.000412	0.00915	CbGeAlD
Pergolide—ADRA2A—endocrine gland—stomach cancer	0.000401	0.00889	CbGeAlD
Pergolide—CYP3A4—digestive system—stomach cancer	0.000382	0.00847	CbGeAlD
Pergolide—CYP2D6—digestive system—stomach cancer	0.000376	0.00833	CbGeAlD
Pergolide—KCNH2—lymph node—stomach cancer	0.000352	0.0078	CbGeAlD
Pergolide—ADRA2C—lymph node—stomach cancer	0.000347	0.0077	CbGeAlD
Pergolide—HTR2A—endocrine gland—stomach cancer	0.000341	0.00756	CbGeAlD
Pergolide—CYP3A4—endocrine gland—stomach cancer	0.000315	0.007	CbGeAlD
Pergolide—CYP2D6—endocrine gland—stomach cancer	0.00031	0.00689	CbGeAlD
Pergolide—HTR2A—liver—stomach cancer	0.000307	0.00681	CbGeAlD
Pergolide—CYP3A4—liver—stomach cancer	0.000284	0.00631	CbGeAlD
Pergolide—CYP2D6—liver—stomach cancer	0.00028	0.00621	CbGeAlD
Pergolide—ADRA2A—lymph node—stomach cancer	0.000277	0.00614	CbGeAlD
Pergolide—Tachycardia—Docetaxel—stomach cancer	0.000141	0.000464	CcSEcCtD
Pergolide—Oedema—Capecitabine—stomach cancer	0.00014	0.00046	CcSEcCtD
Pergolide—Bradycardia—Epirubicin—stomach cancer	0.00014	0.000459	CcSEcCtD
Pergolide—Renal failure—Doxorubicin—stomach cancer	0.000139	0.000457	CcSEcCtD
Pergolide—Infection—Capecitabine—stomach cancer	0.000139	0.000457	CcSEcCtD
Pergolide—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000139	0.000456	CcSEcCtD
Pergolide—Dizziness—Irinotecan—stomach cancer	0.000139	0.000454	CcSEcCtD
Pergolide—Jaundice—Doxorubicin—stomach cancer	0.000138	0.000453	CcSEcCtD
Pergolide—Anorexia—Docetaxel—stomach cancer	0.000138	0.000453	CcSEcCtD
Pergolide—Shock—Capecitabine—stomach cancer	0.000138	0.000452	CcSEcCtD
Pergolide—Rhinitis—Epirubicin—stomach cancer	0.000138	0.000452	CcSEcCtD
Pergolide—Urinary tract infection—Doxorubicin—stomach cancer	0.000138	0.000452	CcSEcCtD
Pergolide—Conjunctivitis—Doxorubicin—stomach cancer	0.000138	0.000452	CcSEcCtD
Pergolide—Hepatitis—Epirubicin—stomach cancer	0.000138	0.000451	CcSEcCtD
Pergolide—Eye disorder—Methotrexate—stomach cancer	0.000137	0.00045	CcSEcCtD
Pergolide—Diarrhoea—Fluorouracil—stomach cancer	0.000137	0.00045	CcSEcCtD
Pergolide—Thrombocytopenia—Capecitabine—stomach cancer	0.000137	0.00045	CcSEcCtD
Pergolide—Tinnitus—Methotrexate—stomach cancer	0.000137	0.000449	CcSEcCtD
Pergolide—Tachycardia—Capecitabine—stomach cancer	0.000137	0.000449	CcSEcCtD
Pergolide—Pharyngitis—Epirubicin—stomach cancer	0.000137	0.000448	CcSEcCtD
Pergolide—Sweating—Doxorubicin—stomach cancer	0.000136	0.000446	CcSEcCtD
Pergolide—Hyperhidrosis—Capecitabine—stomach cancer	0.000136	0.000445	CcSEcCtD
Pergolide—Oedema peripheral—Epirubicin—stomach cancer	0.000136	0.000444	CcSEcCtD
Pergolide—Hypotension—Docetaxel—stomach cancer	0.000135	0.000444	CcSEcCtD
Pergolide—Haematuria—Doxorubicin—stomach cancer	0.000135	0.000443	CcSEcCtD
Pergolide—Epistaxis—Doxorubicin—stomach cancer	0.000134	0.000438	CcSEcCtD
Pergolide—Anorexia—Capecitabine—stomach cancer	0.000134	0.000438	CcSEcCtD
Pergolide—Vomiting—Irinotecan—stomach cancer	0.000133	0.000437	CcSEcCtD
Pergolide—Sinusitis—Doxorubicin—stomach cancer	0.000133	0.000436	CcSEcCtD
Pergolide—Dizziness—Fluorouracil—stomach cancer	0.000133	0.000435	CcSEcCtD
Pergolide—Visual impairment—Epirubicin—stomach cancer	0.000133	0.000435	CcSEcCtD
Pergolide—Rash—Irinotecan—stomach cancer	0.000132	0.000433	CcSEcCtD
Pergolide—Dermatitis—Irinotecan—stomach cancer	0.000132	0.000433	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000132	0.000433	CcSEcCtD
Pergolide—Chills—Methotrexate—stomach cancer	0.000132	0.000432	CcSEcCtD
Pergolide—Headache—Irinotecan—stomach cancer	0.000131	0.00043	CcSEcCtD
Pergolide—Hypotension—Capecitabine—stomach cancer	0.000131	0.00043	CcSEcCtD
Pergolide—Insomnia—Docetaxel—stomach cancer	0.000131	0.00043	CcSEcCtD
Pergolide—Paraesthesia—Docetaxel—stomach cancer	0.00013	0.000427	CcSEcCtD
Pergolide—Alopecia—Methotrexate—stomach cancer	0.00013	0.000426	CcSEcCtD
Pergolide—Bradycardia—Doxorubicin—stomach cancer	0.00013	0.000425	CcSEcCtD
Pergolide—Dyspnoea—Docetaxel—stomach cancer	0.000129	0.000423	CcSEcCtD
Pergolide—Somnolence—Docetaxel—stomach cancer	0.000129	0.000422	CcSEcCtD
Pergolide—Eye disorder—Epirubicin—stomach cancer	0.000129	0.000421	CcSEcCtD
Pergolide—Tinnitus—Epirubicin—stomach cancer	0.000128	0.00042	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000128	0.000419	CcSEcCtD
Pergolide—Vomiting—Fluorouracil—stomach cancer	0.000128	0.000418	CcSEcCtD
Pergolide—Rhinitis—Doxorubicin—stomach cancer	0.000128	0.000418	CcSEcCtD
Pergolide—Dyspepsia—Docetaxel—stomach cancer	0.000128	0.000418	CcSEcCtD
Pergolide—Hepatitis—Doxorubicin—stomach cancer	0.000127	0.000417	CcSEcCtD
Pergolide—Insomnia—Capecitabine—stomach cancer	0.000127	0.000416	CcSEcCtD
Pergolide—Rash—Fluorouracil—stomach cancer	0.000127	0.000415	CcSEcCtD
Pergolide—Dermatitis—Fluorouracil—stomach cancer	0.000127	0.000415	CcSEcCtD
Pergolide—Pharyngitis—Doxorubicin—stomach cancer	0.000126	0.000414	CcSEcCtD
Pergolide—Paraesthesia—Capecitabine—stomach cancer	0.000126	0.000413	CcSEcCtD
Pergolide—Decreased appetite—Docetaxel—stomach cancer	0.000126	0.000413	CcSEcCtD
Pergolide—Headache—Fluorouracil—stomach cancer	0.000126	0.000412	CcSEcCtD
Pergolide—Oedema peripheral—Doxorubicin—stomach cancer	0.000125	0.000411	CcSEcCtD
Pergolide—Dysgeusia—Methotrexate—stomach cancer	0.000125	0.000411	CcSEcCtD
Pergolide—Dyspnoea—Capecitabine—stomach cancer	0.000125	0.00041	CcSEcCtD
Pergolide—Nausea—Irinotecan—stomach cancer	0.000125	0.000408	CcSEcCtD
Pergolide—Pain—Docetaxel—stomach cancer	0.000124	0.000406	CcSEcCtD
Pergolide—Constipation—Docetaxel—stomach cancer	0.000124	0.000406	CcSEcCtD
Pergolide—Back pain—Methotrexate—stomach cancer	0.000124	0.000406	CcSEcCtD
Pergolide—Dyspepsia—Capecitabine—stomach cancer	0.000124	0.000405	CcSEcCtD
Pergolide—Chills—Epirubicin—stomach cancer	0.000123	0.000405	CcSEcCtD
Pergolide—Arrhythmia—Epirubicin—stomach cancer	0.000123	0.000403	CcSEcCtD
Pergolide—Visual impairment—Doxorubicin—stomach cancer	0.000123	0.000402	CcSEcCtD
Pergolide—Decreased appetite—Capecitabine—stomach cancer	0.000122	0.0004	CcSEcCtD
Pergolide—Alopecia—Epirubicin—stomach cancer	0.000122	0.000398	CcSEcCtD
Pergolide—Pain—Capecitabine—stomach cancer	0.00012	0.000393	CcSEcCtD
Pergolide—Constipation—Capecitabine—stomach cancer	0.00012	0.000393	CcSEcCtD
Pergolide—Feeling abnormal—Docetaxel—stomach cancer	0.000119	0.000391	CcSEcCtD
Pergolide—Nausea—Fluorouracil—stomach cancer	0.000119	0.000391	CcSEcCtD
Pergolide—Eye disorder—Doxorubicin—stomach cancer	0.000119	0.00039	CcSEcCtD
Pergolide—Ill-defined disorder—Methotrexate—stomach cancer	0.000119	0.000389	CcSEcCtD
Pergolide—Tinnitus—Doxorubicin—stomach cancer	0.000119	0.000389	CcSEcCtD
Pergolide—Gastrointestinal pain—Docetaxel—stomach cancer	0.000119	0.000388	CcSEcCtD
Pergolide—Anaemia—Methotrexate—stomach cancer	0.000118	0.000388	CcSEcCtD
Pergolide—Flatulence—Epirubicin—stomach cancer	0.000118	0.000387	CcSEcCtD
Pergolide—Tension—Epirubicin—stomach cancer	0.000118	0.000385	CcSEcCtD
Pergolide—Dysgeusia—Epirubicin—stomach cancer	0.000117	0.000384	CcSEcCtD
Pergolide—Nervousness—Epirubicin—stomach cancer	0.000116	0.000381	CcSEcCtD
Pergolide—Back pain—Epirubicin—stomach cancer	0.000116	0.00038	CcSEcCtD
Pergolide—Feeling abnormal—Capecitabine—stomach cancer	0.000116	0.000379	CcSEcCtD
Pergolide—Malaise—Methotrexate—stomach cancer	0.000115	0.000378	CcSEcCtD
Pergolide—Vertigo—Methotrexate—stomach cancer	0.000115	0.000377	CcSEcCtD
Pergolide—Gastrointestinal pain—Capecitabine—stomach cancer	0.000115	0.000376	CcSEcCtD
Pergolide—Abdominal pain—Docetaxel—stomach cancer	0.000115	0.000375	CcSEcCtD
Pergolide—Body temperature increased—Docetaxel—stomach cancer	0.000115	0.000375	CcSEcCtD
Pergolide—Leukopenia—Methotrexate—stomach cancer	0.000115	0.000375	CcSEcCtD
Pergolide—Chills—Doxorubicin—stomach cancer	0.000114	0.000374	CcSEcCtD
Pergolide—Arrhythmia—Doxorubicin—stomach cancer	0.000114	0.000373	CcSEcCtD
Pergolide—Alopecia—Doxorubicin—stomach cancer	0.000113	0.000369	CcSEcCtD
Pergolide—Cough—Methotrexate—stomach cancer	0.000112	0.000366	CcSEcCtD
Pergolide—Ill-defined disorder—Epirubicin—stomach cancer	0.000111	0.000364	CcSEcCtD
Pergolide—Abdominal pain—Capecitabine—stomach cancer	0.000111	0.000364	CcSEcCtD
Pergolide—Body temperature increased—Capecitabine—stomach cancer	0.000111	0.000364	CcSEcCtD
Pergolide—Convulsion—Methotrexate—stomach cancer	0.000111	0.000363	CcSEcCtD
Pergolide—Anaemia—Epirubicin—stomach cancer	0.000111	0.000363	CcSEcCtD
Pergolide—Agitation—Epirubicin—stomach cancer	0.00011	0.000361	CcSEcCtD
Pergolide—Flatulence—Doxorubicin—stomach cancer	0.000109	0.000358	CcSEcCtD
Pergolide—Chest pain—Methotrexate—stomach cancer	0.000109	0.000357	CcSEcCtD
Pergolide—Myalgia—Methotrexate—stomach cancer	0.000109	0.000357	CcSEcCtD
Pergolide—Arthralgia—Methotrexate—stomach cancer	0.000109	0.000357	CcSEcCtD
Pergolide—Tension—Doxorubicin—stomach cancer	0.000109	0.000356	CcSEcCtD
Pergolide—Dysgeusia—Doxorubicin—stomach cancer	0.000109	0.000356	CcSEcCtD
Pergolide—Malaise—Epirubicin—stomach cancer	0.000108	0.000354	CcSEcCtD
Pergolide—Discomfort—Methotrexate—stomach cancer	0.000108	0.000353	CcSEcCtD
Pergolide—Nervousness—Doxorubicin—stomach cancer	0.000108	0.000353	CcSEcCtD
Pergolide—Vertigo—Epirubicin—stomach cancer	0.000108	0.000353	CcSEcCtD
Pergolide—Syncope—Epirubicin—stomach cancer	0.000107	0.000352	CcSEcCtD
Pergolide—Leukopenia—Epirubicin—stomach cancer	0.000107	0.000351	CcSEcCtD
Pergolide—Back pain—Doxorubicin—stomach cancer	0.000107	0.000351	CcSEcCtD
Pergolide—Palpitations—Epirubicin—stomach cancer	0.000106	0.000347	CcSEcCtD
Pergolide—Confusional state—Methotrexate—stomach cancer	0.000105	0.000345	CcSEcCtD
Pergolide—Loss of consciousness—Epirubicin—stomach cancer	0.000105	0.000345	CcSEcCtD
Pergolide—Cough—Epirubicin—stomach cancer	0.000105	0.000343	CcSEcCtD
Pergolide—Asthenia—Docetaxel—stomach cancer	0.000104	0.000341	CcSEcCtD
Pergolide—Convulsion—Epirubicin—stomach cancer	0.000104	0.00034	CcSEcCtD
Pergolide—Infection—Methotrexate—stomach cancer	0.000104	0.00034	CcSEcCtD
Pergolide—Hypertension—Epirubicin—stomach cancer	0.000103	0.000339	CcSEcCtD
Pergolide—Ill-defined disorder—Doxorubicin—stomach cancer	0.000103	0.000337	CcSEcCtD
Pergolide—Pruritus—Docetaxel—stomach cancer	0.000103	0.000336	CcSEcCtD
Pergolide—Anaemia—Doxorubicin—stomach cancer	0.000102	0.000336	CcSEcCtD
Pergolide—Thrombocytopenia—Methotrexate—stomach cancer	0.000102	0.000335	CcSEcCtD
Pergolide—Myalgia—Epirubicin—stomach cancer	0.000102	0.000334	CcSEcCtD
Pergolide—Arthralgia—Epirubicin—stomach cancer	0.000102	0.000334	CcSEcCtD
Pergolide—Chest pain—Epirubicin—stomach cancer	0.000102	0.000334	CcSEcCtD
Pergolide—Agitation—Doxorubicin—stomach cancer	0.000102	0.000334	CcSEcCtD
Pergolide—Anxiety—Epirubicin—stomach cancer	0.000102	0.000333	CcSEcCtD
Pergolide—Hyperhidrosis—Methotrexate—stomach cancer	0.000101	0.000331	CcSEcCtD
Pergolide—Discomfort—Epirubicin—stomach cancer	0.000101	0.00033	CcSEcCtD
Pergolide—Asthenia—Capecitabine—stomach cancer	0.000101	0.00033	CcSEcCtD
Pergolide—Malaise—Doxorubicin—stomach cancer	0.0001	0.000328	CcSEcCtD
Pergolide—Dry mouth—Epirubicin—stomach cancer	9.98e-05	0.000327	CcSEcCtD
Pergolide—Vertigo—Doxorubicin—stomach cancer	9.96e-05	0.000326	CcSEcCtD
Pergolide—Anorexia—Methotrexate—stomach cancer	9.96e-05	0.000326	CcSEcCtD
Pergolide—Syncope—Doxorubicin—stomach cancer	9.94e-05	0.000326	CcSEcCtD
Pergolide—Pruritus—Capecitabine—stomach cancer	9.93e-05	0.000325	CcSEcCtD
Pergolide—Leukopenia—Doxorubicin—stomach cancer	9.92e-05	0.000325	CcSEcCtD
Pergolide—Diarrhoea—Docetaxel—stomach cancer	9.92e-05	0.000325	CcSEcCtD
Pergolide—Confusional state—Epirubicin—stomach cancer	9.86e-05	0.000323	CcSEcCtD
Pergolide—Palpitations—Doxorubicin—stomach cancer	9.8e-05	0.000321	CcSEcCtD
Pergolide—Oedema—Epirubicin—stomach cancer	9.78e-05	0.00032	CcSEcCtD
Pergolide—Hypotension—Methotrexate—stomach cancer	9.76e-05	0.00032	CcSEcCtD
Pergolide—Loss of consciousness—Doxorubicin—stomach cancer	9.74e-05	0.000319	CcSEcCtD
Pergolide—Infection—Epirubicin—stomach cancer	9.71e-05	0.000318	CcSEcCtD
Pergolide—Cough—Doxorubicin—stomach cancer	9.67e-05	0.000317	CcSEcCtD
Pergolide—Shock—Epirubicin—stomach cancer	9.62e-05	0.000315	CcSEcCtD
Pergolide—Convulsion—Doxorubicin—stomach cancer	9.6e-05	0.000315	CcSEcCtD
Pergolide—Diarrhoea—Capecitabine—stomach cancer	9.6e-05	0.000315	CcSEcCtD
Pergolide—Dizziness—Docetaxel—stomach cancer	9.59e-05	0.000314	CcSEcCtD
Pergolide—Thrombocytopenia—Epirubicin—stomach cancer	9.57e-05	0.000314	CcSEcCtD
Pergolide—Hypertension—Doxorubicin—stomach cancer	9.57e-05	0.000314	CcSEcCtD
Pergolide—Tachycardia—Epirubicin—stomach cancer	9.54e-05	0.000313	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Methotrexate—stomach cancer	9.52e-05	0.000312	CcSEcCtD
Pergolide—Hyperhidrosis—Epirubicin—stomach cancer	9.45e-05	0.00031	CcSEcCtD
Pergolide—Insomnia—Methotrexate—stomach cancer	9.45e-05	0.00031	CcSEcCtD
Pergolide—Chest pain—Doxorubicin—stomach cancer	9.44e-05	0.000309	CcSEcCtD
Pergolide—Arthralgia—Doxorubicin—stomach cancer	9.44e-05	0.000309	CcSEcCtD
Pergolide—Myalgia—Doxorubicin—stomach cancer	9.44e-05	0.000309	CcSEcCtD
Pergolide—Anxiety—Doxorubicin—stomach cancer	9.4e-05	0.000308	CcSEcCtD
Pergolide—Paraesthesia—Methotrexate—stomach cancer	9.38e-05	0.000307	CcSEcCtD
Pergolide—Discomfort—Doxorubicin—stomach cancer	9.32e-05	0.000306	CcSEcCtD
Pergolide—Anorexia—Epirubicin—stomach cancer	9.32e-05	0.000305	CcSEcCtD
Pergolide—Dyspnoea—Methotrexate—stomach cancer	9.31e-05	0.000305	CcSEcCtD
Pergolide—Somnolence—Methotrexate—stomach cancer	9.29e-05	0.000304	CcSEcCtD
Pergolide—Dizziness—Capecitabine—stomach cancer	9.28e-05	0.000304	CcSEcCtD
Pergolide—Dry mouth—Doxorubicin—stomach cancer	9.23e-05	0.000302	CcSEcCtD
Pergolide—Vomiting—Docetaxel—stomach cancer	9.22e-05	0.000302	CcSEcCtD
Pergolide—Dyspepsia—Methotrexate—stomach cancer	9.2e-05	0.000301	CcSEcCtD
Pergolide—Rash—Docetaxel—stomach cancer	9.14e-05	0.000299	CcSEcCtD
Pergolide—Hypotension—Epirubicin—stomach cancer	9.14e-05	0.000299	CcSEcCtD
Pergolide—Dermatitis—Docetaxel—stomach cancer	9.13e-05	0.000299	CcSEcCtD
Pergolide—Confusional state—Doxorubicin—stomach cancer	9.12e-05	0.000299	CcSEcCtD
Pergolide—Decreased appetite—Methotrexate—stomach cancer	9.08e-05	0.000298	CcSEcCtD
Pergolide—Headache—Docetaxel—stomach cancer	9.08e-05	0.000298	CcSEcCtD
Pergolide—Oedema—Doxorubicin—stomach cancer	9.05e-05	0.000296	CcSEcCtD
Pergolide—Infection—Doxorubicin—stomach cancer	8.99e-05	0.000295	CcSEcCtD
Pergolide—Pain—Methotrexate—stomach cancer	8.93e-05	0.000293	CcSEcCtD
Pergolide—Vomiting—Capecitabine—stomach cancer	8.92e-05	0.000292	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Epirubicin—stomach cancer	8.91e-05	0.000292	CcSEcCtD
Pergolide—Shock—Doxorubicin—stomach cancer	8.9e-05	0.000292	CcSEcCtD
Pergolide—Thrombocytopenia—Doxorubicin—stomach cancer	8.86e-05	0.00029	CcSEcCtD
Pergolide—Rash—Capecitabine—stomach cancer	8.85e-05	0.00029	CcSEcCtD
Pergolide—Insomnia—Epirubicin—stomach cancer	8.84e-05	0.00029	CcSEcCtD
Pergolide—Dermatitis—Capecitabine—stomach cancer	8.84e-05	0.00029	CcSEcCtD
Pergolide—Tachycardia—Doxorubicin—stomach cancer	8.83e-05	0.000289	CcSEcCtD
Pergolide—Headache—Capecitabine—stomach cancer	8.79e-05	0.000288	CcSEcCtD
Pergolide—Paraesthesia—Epirubicin—stomach cancer	8.78e-05	0.000288	CcSEcCtD
Pergolide—Hyperhidrosis—Doxorubicin—stomach cancer	8.75e-05	0.000287	CcSEcCtD
Pergolide—Dyspnoea—Epirubicin—stomach cancer	8.72e-05	0.000286	CcSEcCtD
Pergolide—Somnolence—Epirubicin—stomach cancer	8.69e-05	0.000285	CcSEcCtD
Pergolide—Anorexia—Doxorubicin—stomach cancer	8.62e-05	0.000283	CcSEcCtD
Pergolide—Nausea—Docetaxel—stomach cancer	8.61e-05	0.000282	CcSEcCtD
Pergolide—Feeling abnormal—Methotrexate—stomach cancer	8.61e-05	0.000282	CcSEcCtD
Pergolide—Dyspepsia—Epirubicin—stomach cancer	8.61e-05	0.000282	CcSEcCtD
Pergolide—Gastrointestinal pain—Methotrexate—stomach cancer	8.54e-05	0.00028	CcSEcCtD
Pergolide—Decreased appetite—Epirubicin—stomach cancer	8.5e-05	0.000279	CcSEcCtD
Pergolide—Hypotension—Doxorubicin—stomach cancer	8.45e-05	0.000277	CcSEcCtD
Pergolide—Pain—Epirubicin—stomach cancer	8.36e-05	0.000274	CcSEcCtD
Pergolide—Constipation—Epirubicin—stomach cancer	8.36e-05	0.000274	CcSEcCtD
Pergolide—Nausea—Capecitabine—stomach cancer	8.34e-05	0.000273	CcSEcCtD
Pergolide—Abdominal pain—Methotrexate—stomach cancer	8.26e-05	0.000271	CcSEcCtD
Pergolide—Body temperature increased—Methotrexate—stomach cancer	8.26e-05	0.000271	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	8.24e-05	0.00027	CcSEcCtD
Pergolide—Insomnia—Doxorubicin—stomach cancer	8.18e-05	0.000268	CcSEcCtD
Pergolide—Paraesthesia—Doxorubicin—stomach cancer	8.12e-05	0.000266	CcSEcCtD
Pergolide—Dyspnoea—Doxorubicin—stomach cancer	8.07e-05	0.000264	CcSEcCtD
Pergolide—Feeling abnormal—Epirubicin—stomach cancer	8.06e-05	0.000264	CcSEcCtD
Pergolide—Somnolence—Doxorubicin—stomach cancer	8.04e-05	0.000264	CcSEcCtD
Pergolide—Gastrointestinal pain—Epirubicin—stomach cancer	8e-05	0.000262	CcSEcCtD
Pergolide—Dyspepsia—Doxorubicin—stomach cancer	7.96e-05	0.000261	CcSEcCtD
Pergolide—Decreased appetite—Doxorubicin—stomach cancer	7.86e-05	0.000258	CcSEcCtD
Pergolide—Pain—Doxorubicin—stomach cancer	7.74e-05	0.000253	CcSEcCtD
Pergolide—Constipation—Doxorubicin—stomach cancer	7.74e-05	0.000253	CcSEcCtD
Pergolide—Abdominal pain—Epirubicin—stomach cancer	7.73e-05	0.000253	CcSEcCtD
Pergolide—Body temperature increased—Epirubicin—stomach cancer	7.73e-05	0.000253	CcSEcCtD
Pergolide—Asthenia—Methotrexate—stomach cancer	7.5e-05	0.000246	CcSEcCtD
Pergolide—Feeling abnormal—Doxorubicin—stomach cancer	7.46e-05	0.000244	CcSEcCtD
Pergolide—Gastrointestinal pain—Doxorubicin—stomach cancer	7.4e-05	0.000242	CcSEcCtD
Pergolide—Pruritus—Methotrexate—stomach cancer	7.39e-05	0.000242	CcSEcCtD
Pergolide—Body temperature increased—Doxorubicin—stomach cancer	7.15e-05	0.000234	CcSEcCtD
Pergolide—Abdominal pain—Doxorubicin—stomach cancer	7.15e-05	0.000234	CcSEcCtD
Pergolide—Diarrhoea—Methotrexate—stomach cancer	7.15e-05	0.000234	CcSEcCtD
Pergolide—Asthenia—Epirubicin—stomach cancer	7.02e-05	0.00023	CcSEcCtD
Pergolide—Pruritus—Epirubicin—stomach cancer	6.92e-05	0.000227	CcSEcCtD
Pergolide—Dizziness—Methotrexate—stomach cancer	6.91e-05	0.000226	CcSEcCtD
Pergolide—Diarrhoea—Epirubicin—stomach cancer	6.69e-05	0.000219	CcSEcCtD
Pergolide—Vomiting—Methotrexate—stomach cancer	6.64e-05	0.000218	CcSEcCtD
Pergolide—Rash—Methotrexate—stomach cancer	6.59e-05	0.000216	CcSEcCtD
Pergolide—Dermatitis—Methotrexate—stomach cancer	6.58e-05	0.000216	CcSEcCtD
Pergolide—Headache—Methotrexate—stomach cancer	6.55e-05	0.000214	CcSEcCtD
Pergolide—Asthenia—Doxorubicin—stomach cancer	6.49e-05	0.000213	CcSEcCtD
Pergolide—Dizziness—Epirubicin—stomach cancer	6.47e-05	0.000212	CcSEcCtD
Pergolide—Pruritus—Doxorubicin—stomach cancer	6.4e-05	0.00021	CcSEcCtD
Pergolide—Vomiting—Epirubicin—stomach cancer	6.22e-05	0.000204	CcSEcCtD
Pergolide—Nausea—Methotrexate—stomach cancer	6.21e-05	0.000203	CcSEcCtD
Pergolide—Diarrhoea—Doxorubicin—stomach cancer	6.19e-05	0.000203	CcSEcCtD
Pergolide—Rash—Epirubicin—stomach cancer	6.16e-05	0.000202	CcSEcCtD
Pergolide—Dermatitis—Epirubicin—stomach cancer	6.16e-05	0.000202	CcSEcCtD
Pergolide—Headache—Epirubicin—stomach cancer	6.13e-05	0.000201	CcSEcCtD
Pergolide—Dizziness—Doxorubicin—stomach cancer	5.98e-05	0.000196	CcSEcCtD
Pergolide—Nausea—Epirubicin—stomach cancer	5.81e-05	0.00019	CcSEcCtD
Pergolide—Vomiting—Doxorubicin—stomach cancer	5.75e-05	0.000188	CcSEcCtD
Pergolide—Rash—Doxorubicin—stomach cancer	5.7e-05	0.000187	CcSEcCtD
Pergolide—Dermatitis—Doxorubicin—stomach cancer	5.7e-05	0.000187	CcSEcCtD
Pergolide—Headache—Doxorubicin—stomach cancer	5.67e-05	0.000186	CcSEcCtD
Pergolide—Nausea—Doxorubicin—stomach cancer	5.37e-05	0.000176	CcSEcCtD
Pergolide—DRD1—Signaling Pathways—STAT3—stomach cancer	5.12e-06	2.88e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	5.11e-06	2.87e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—stomach cancer	5.1e-06	2.87e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	5.1e-06	2.87e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CCND1—stomach cancer	5.1e-06	2.86e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	5.09e-06	2.86e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—JUN—stomach cancer	5.09e-06	2.86e-05	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	5.08e-06	2.86e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	5.08e-06	2.85e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	5.07e-06	2.85e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CCND1—stomach cancer	5.07e-06	2.85e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ERBB2—stomach cancer	5.06e-06	2.85e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—KRAS—stomach cancer	5.06e-06	2.85e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—JUN—stomach cancer	5.06e-06	2.84e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—STAT3—stomach cancer	5.05e-06	2.84e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—STAT3—stomach cancer	5.05e-06	2.84e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MYC—stomach cancer	5.04e-06	2.83e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—stomach cancer	5.03e-06	2.83e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	5.03e-06	2.83e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CAV1—stomach cancer	5e-06	2.81e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	4.98e-06	2.8e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOA1—stomach cancer	4.98e-06	2.8e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ERBB2—stomach cancer	4.98e-06	2.8e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	4.97e-06	2.79e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—KRAS—stomach cancer	4.96e-06	2.79e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—stomach cancer	4.95e-06	2.78e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—stomach cancer	4.95e-06	2.78e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MAPK1—stomach cancer	4.93e-06	2.77e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CCND1—stomach cancer	4.93e-06	2.77e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EGFR—stomach cancer	4.93e-06	2.77e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	4.93e-06	2.77e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—stomach cancer	4.92e-06	2.77e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—JUN—stomach cancer	4.92e-06	2.77e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	4.9e-06	2.76e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RHOA—stomach cancer	4.9e-06	2.75e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MAPK3—stomach cancer	4.89e-06	2.75e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	4.88e-06	2.74e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—KRAS—stomach cancer	4.88e-06	2.74e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CCND1—stomach cancer	4.85e-06	2.73e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NOS3—stomach cancer	4.85e-06	2.72e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—JUN—stomach cancer	4.84e-06	2.72e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MAPK3—stomach cancer	4.82e-06	2.71e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	4.82e-06	2.71e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK8—stomach cancer	4.81e-06	2.71e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL8—stomach cancer	4.8e-06	2.7e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—stomach cancer	4.79e-06	2.69e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK8—stomach cancer	4.79e-06	2.69e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—HRAS—stomach cancer	4.77e-06	2.68e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	4.77e-06	2.68e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MYC—stomach cancer	4.75e-06	2.67e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL8—stomach cancer	4.73e-06	2.66e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—stomach cancer	4.71e-06	2.65e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—HRAS—stomach cancer	4.69e-06	2.64e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	4.69e-06	2.64e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CDKN1B—stomach cancer	4.69e-06	2.64e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MYC—stomach cancer	4.69e-06	2.64e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MYC—stomach cancer	4.69e-06	2.64e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—KRAS—stomach cancer	4.66e-06	2.62e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	4.66e-06	2.62e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—PIK3CA—stomach cancer	4.65e-06	2.62e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MAPK1—stomach cancer	4.65e-06	2.61e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EGFR—stomach cancer	4.65e-06	2.61e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	4.63e-06	2.6e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	4.62e-06	2.6e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	4.61e-06	2.59e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	4.6e-06	2.59e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	4.6e-06	2.58e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MAPK1—stomach cancer	4.59e-06	2.58e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	4.59e-06	2.58e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EGFR—stomach cancer	4.59e-06	2.58e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EGFR—stomach cancer	4.59e-06	2.58e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	4.58e-06	2.58e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—stomach cancer	4.57e-06	2.57e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—STAT3—stomach cancer	4.56e-06	2.56e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	4.56e-06	2.56e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	4.53e-06	2.55e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	4.52e-06	2.54e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—stomach cancer	4.5e-06	2.53e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—stomach cancer	4.49e-06	2.53e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PIK3CA—stomach cancer	4.48e-06	2.52e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CCND1—stomach cancer	4.47e-06	2.52e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—JUN—stomach cancer	4.46e-06	2.51e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.44e-06	2.5e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—stomach cancer	4.44e-06	2.5e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—stomach cancer	4.42e-06	2.48e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—stomach cancer	4.41e-06	2.48e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CCND1—stomach cancer	4.4e-06	2.48e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—stomach cancer	4.4e-06	2.47e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—STAT3—stomach cancer	4.4e-06	2.47e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—JUN—stomach cancer	4.39e-06	2.47e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—KRAS—stomach cancer	4.39e-06	2.47e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PPARG—stomach cancer	4.39e-06	2.47e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—STAT3—stomach cancer	4.38e-06	2.46e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTP1—stomach cancer	4.36e-06	2.45e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	4.35e-06	2.45e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—stomach cancer	4.34e-06	2.44e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—stomach cancer	4.34e-06	2.44e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—KRAS—stomach cancer	4.33e-06	2.44e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—KRAS—stomach cancer	4.33e-06	2.44e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CDKN1A—stomach cancer	4.33e-06	2.43e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CCND1—stomach cancer	4.31e-06	2.42e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—HRAS—stomach cancer	4.3e-06	2.42e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—JUN—stomach cancer	4.3e-06	2.42e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMOX1—stomach cancer	4.3e-06	2.42e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	4.3e-06	2.42e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	4.3e-06	2.42e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	4.28e-06	2.41e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—stomach cancer	4.27e-06	2.4e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	4.27e-06	2.4e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	4.26e-06	2.39e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—STAT3—stomach cancer	4.26e-06	2.39e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—stomach cancer	4.23e-06	2.38e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	4.23e-06	2.38e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK8—stomach cancer	4.22e-06	2.38e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—HRAS—stomach cancer	4.21e-06	2.37e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK3—stomach cancer	4.2e-06	2.36e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	4.2e-06	2.36e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—STAT3—stomach cancer	4.19e-06	2.36e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—stomach cancer	4.19e-06	2.35e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK3—stomach cancer	4.18e-06	2.35e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	4.17e-06	2.34e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK8—stomach cancer	4.16e-06	2.34e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—HRAS—stomach cancer	4.15e-06	2.33e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	4.14e-06	2.33e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EGFR—stomach cancer	4.14e-06	2.33e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—stomach cancer	4.14e-06	2.33e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—stomach cancer	4.12e-06	2.32e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—stomach cancer	4.09e-06	2.3e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—stomach cancer	4.09e-06	2.3e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	4.07e-06	2.29e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	4.07e-06	2.29e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—stomach cancer	4.07e-06	2.29e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TYMS—stomach cancer	4.05e-06	2.28e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PIK3CA—stomach cancer	4.04e-06	2.27e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—stomach cancer	4.03e-06	2.27e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PIK3CA—stomach cancer	4.02e-06	2.26e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTM1—stomach cancer	4.01e-06	2.25e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CCND1—stomach cancer	4.01e-06	2.25e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	4e-06	2.25e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MAPK1—stomach cancer	4e-06	2.25e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EGFR—stomach cancer	4e-06	2.25e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—JUN—stomach cancer	4e-06	2.25e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	3.98e-06	2.24e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PIK3CA—stomach cancer	3.98e-06	2.24e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MAPK1—stomach cancer	3.98e-06	2.24e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EGFR—stomach cancer	3.98e-06	2.24e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—stomach cancer	3.97e-06	2.23e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—HRAS—stomach cancer	3.96e-06	2.23e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—stomach cancer	3.96e-06	2.22e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—stomach cancer	3.95e-06	2.22e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—KRAS—stomach cancer	3.91e-06	2.2e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—stomach cancer	3.9e-06	2.19e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—stomach cancer	3.9e-06	2.19e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—stomach cancer	3.89e-06	2.19e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—stomach cancer	3.89e-06	2.19e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	3.87e-06	2.18e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	3.87e-06	2.18e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EGFR—stomach cancer	3.87e-06	2.17e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—STAT3—stomach cancer	3.86e-06	2.17e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—stomach cancer	3.85e-06	2.17e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—stomach cancer	3.85e-06	2.17e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—stomach cancer	3.84e-06	2.16e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	3.81e-06	2.14e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EGFR—stomach cancer	3.81e-06	2.14e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—STAT3—stomach cancer	3.8e-06	2.14e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—stomach cancer	3.79e-06	2.13e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	3.78e-06	2.13e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NOS3—stomach cancer	3.78e-06	2.12e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—KRAS—stomach cancer	3.78e-06	2.12e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ERCC2—stomach cancer	3.77e-06	2.12e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	3.76e-06	2.11e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—KRAS—stomach cancer	3.76e-06	2.11e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—HRAS—stomach cancer	3.73e-06	2.1e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—STAT3—stomach cancer	3.72e-06	2.09e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK3—stomach cancer	3.69e-06	2.07e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—HRAS—stomach cancer	3.68e-06	2.07e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—HRAS—stomach cancer	3.68e-06	2.07e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—KRAS—stomach cancer	3.65e-06	2.05e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK3—stomach cancer	3.63e-06	2.04e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—KRAS—stomach cancer	3.6e-06	2.02e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	3.59e-06	2.02e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—stomach cancer	3.59e-06	2.02e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—stomach cancer	3.57e-06	2.01e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	3.56e-06	2e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTHFR—stomach cancer	3.54e-06	1.99e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—stomach cancer	3.53e-06	1.99e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—stomach cancer	3.53e-06	1.98e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—stomach cancer	3.53e-06	1.98e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MAPK1—stomach cancer	3.51e-06	1.97e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EGFR—stomach cancer	3.51e-06	1.97e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	3.49e-06	1.96e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—stomach cancer	3.48e-06	1.95e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	3.47e-06	1.95e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—stomach cancer	3.46e-06	1.94e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—STAT3—stomach cancer	3.46e-06	1.94e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MAPK1—stomach cancer	3.45e-06	1.94e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—stomach cancer	3.45e-06	1.94e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EGFR—stomach cancer	3.45e-06	1.94e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	3.45e-06	1.94e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	3.38e-06	1.9e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EGFR—stomach cancer	3.38e-06	1.9e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	3.36e-06	1.89e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—stomach cancer	3.36e-06	1.89e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—stomach cancer	3.34e-06	1.88e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—HRAS—stomach cancer	3.33e-06	1.87e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—KRAS—stomach cancer	3.32e-06	1.86e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	3.3e-06	1.86e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	3.3e-06	1.86e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CAV1—stomach cancer	3.27e-06	1.84e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—KRAS—stomach cancer	3.26e-06	1.83e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PIK3CA—stomach cancer	3.26e-06	1.83e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOA1—stomach cancer	3.26e-06	1.83e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—stomach cancer	3.25e-06	1.83e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—stomach cancer	3.21e-06	1.81e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—HRAS—stomach cancer	3.21e-06	1.8e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—stomach cancer	3.2e-06	1.8e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—KRAS—stomach cancer	3.19e-06	1.8e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—HRAS—stomach cancer	3.19e-06	1.8e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—stomach cancer	3.18e-06	1.79e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	3.14e-06	1.77e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EGFR—stomach cancer	3.14e-06	1.77e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—HRAS—stomach cancer	3.11e-06	1.75e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—stomach cancer	3.07e-06	1.73e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—HRAS—stomach cancer	3.06e-06	1.72e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—stomach cancer	3.06e-06	1.72e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PIK3CA—stomach cancer	3.05e-06	1.71e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	3e-06	1.69e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—stomach cancer	2.97e-06	1.67e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KRAS—stomach cancer	2.97e-06	1.67e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—stomach cancer	2.95e-06	1.66e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	2.94e-06	1.65e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—stomach cancer	2.93e-06	1.65e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—stomach cancer	2.9e-06	1.63e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PPARG—stomach cancer	2.87e-06	1.61e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.84e-06	1.6e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—HRAS—stomach cancer	2.82e-06	1.58e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—HRAS—stomach cancer	2.77e-06	1.56e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	2.73e-06	1.53e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.72e-06	1.53e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—stomach cancer	2.7e-06	1.52e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—stomach cancer	2.65e-06	1.49e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—stomach cancer	2.64e-06	1.48e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—stomach cancer	2.6e-06	1.46e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—stomach cancer	2.58e-06	1.45e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—HRAS—stomach cancer	2.52e-06	1.42e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NOS3—stomach cancer	2.47e-06	1.39e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—stomach cancer	2.41e-06	1.36e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—stomach cancer	2.26e-06	1.27e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.39e-06	7.81e-06	CbGpPWpGaD
